Tin tức & Cập nhật

Chỉ hiển thị Multimedia

Delgocitinib cream safe, effective for long-term use in eczema

07 Jul 2025 bởi

Long-term treatment with delgocitinib is well-tolerated and raises no major safety concerns among patients with chronic hand eczema (CHE), results of the DELTA 3 trial have shown. Its use also maintains disease control for up to 52 weeks.

Delgocitinib cream safe, effective for long-term use in eczema

07 Jul 2025

Topical BRAF inhibitor relieves EGFR-induced acneiform eruption

07 Jul 2025 bởi

LUT014 gel, a novel, small-molecule, topical formulation of a BRAF inhibitor, relieves acneiform rash toxicities from anti-EGFR therapies, findings from a phase II study suggest.

Topical BRAF inhibitor relieves EGFR-induced acneiform eruption

07 Jul 2025

ICIs improve survival in advanced MCC at population level

30 Jun 2025

Treatment of immune checkpoint inhibitors (ICIs) has led to a more than twofold increase in survival for patients with advanced Merkel cell carcinoma (MCC) at the population level, translating to about 220 fewer deaths annually in the US, according to a study.

ICIs improve survival in advanced MCC at population level

30 Jun 2025

Early HCQ treatment prevents progression of CLE to SLE

29 Jun 2025

Early initiation of hydroxychloroquine (HCQ) protects patients with cutaneous lupus erythematosus (CLE) from progressing to systemic lupus erythematosus (SLE), a recent study has shown.

Early HCQ treatment prevents progression of CLE to SLE

29 Jun 2025

Original New Drug Application Approvals by US FDA (16-31 May 2025)

23 Jun 2025

New drug applications approved by US FDA as of 16-31 May 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 May 2025)

23 Jun 2025

Risk of death higher in people with vs without psoriasis

21 Jun 2025

Individuals with psoriatic disease (PsD) are at greater risk of all-cause mortality than those without PsD, reveals a Taiwan study. Specifically, the risk of death is higher in patients with psoriasis but not in those with psoriatic arthritis (PsA).

Risk of death higher in people with vs without psoriasis

21 Jun 2025

Chronic medical, psychiatric comorbidities common in paediatric hidradenitis suppurativa

21 Jun 2025

Children with hidradenitis suppurativa (HS) are prone to a number of metabolic, endocrinologic, dermatologic, psychiatric, and genetic comorbidities, including obesity, anxiety, and acne vulgaris, according to the findings of a systematic review and meta-analysis.

Chronic medical, psychiatric comorbidities common in paediatric hidradenitis suppurativa

21 Jun 2025

Adalimumab delivers consistent benefit in plaque psoriasis, with or without methotrexate

18 Jun 2025

Treatment outcomes with adalimumab for plaque psoriasis appear to be similar between patients on monotherapy and those receiving concomitant methotrexate, according to the BSTOP study.

Adalimumab delivers consistent benefit in plaque psoriasis, with or without methotrexate

18 Jun 2025

Modified minocycline hydrochloride formulation works against papulopustular rosacea

02 Jun 2025

In the treatment of moderate-to-severe papulopustular rosacea (PPR), the low-dose modified formulation of minocycline hydrochloride, DFD-29, appears to have superior efficacy compared with both doxycycline and placebo, according to data from the phase III MVOR-1 and MVOR-2 studies.

Modified minocycline hydrochloride formulation works against papulopustular rosacea

02 Jun 2025

Androgenetic alopecia may develop in prepubertal patients

28 May 2025

Prepubertal children can develop androgenetic alopecia (AGA), suggests a study. Obesity and family history are associated with an increased risk for paediatric AGA.

Androgenetic alopecia may develop in prepubertal patients

28 May 2025

Tin tức & Cập nhật

Xem bài viết Da liễu

Xem

Chuyên ngành:

Delgocitinib cream safe, effective for long-term use in eczema

Delgocitinib cream safe, effective for long-term use in eczema

Topical BRAF inhibitor relieves EGFR-induced acneiform eruption

Topical BRAF inhibitor relieves EGFR-induced acneiform eruption

ICIs improve survival in advanced MCC at population level

ICIs improve survival in advanced MCC at population level

Early HCQ treatment prevents progression of CLE to SLE

Early HCQ treatment prevents progression of CLE to SLE

Original New Drug Application Approvals by US FDA (16-31 May 2025)

Original New Drug Application Approvals by US FDA (16-31 May 2025)

Risk of death higher in people with vs without psoriasis

Risk of death higher in people with vs without psoriasis

Chronic medical, psychiatric comorbidities common in paediatric hidradenitis suppurativa

Chronic medical, psychiatric comorbidities common in paediatric hidradenitis suppurativa

Adalimumab delivers consistent benefit in plaque psoriasis, with or without methotrexate

Adalimumab delivers consistent benefit in plaque psoriasis, with or without methotrexate

Modified minocycline hydrochloride formulation works against papulopustular rosacea

Modified minocycline hydrochloride formulation works against papulopustular rosacea

Androgenetic alopecia may develop in prepubertal patients

Androgenetic alopecia may develop in prepubertal patients